EUVIMEDEUVIMED entdecken
Crossref

Endocrine response assessment by Ki67: Concordance of central versus local Ki67 measurements in the ADAPTcycle trial

M. Hamann, O. Gluz, M. Christgen, U. Nitz, S. Kuemmel, M. Braun, M. Thill, R. Wuerstlein, P. Wimberger, A. Hartkopf, C. Schem, M. Zaiss und 16 weitere

Senologie - Zeitschrift für Mammadiagnostik und -therapie · 01.06.2024 · 21 (02) · e11-e12

DOI: 10.1055/s-0044-1786090 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Senologie - Zeitschrift für Mammadiagnostik und -therapie, erschienen am 01.06.2024. Verfasst von M. Hamann und 27 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In the ADAPTcycle trial, post-endocrine Ki67 (Ki67 post ) 10% locally, of which only 265 (6.6%) had central Ki67≤10%. Mean post-endocrine Ki67 central (n=4,429) vs. local (n=2,786) measurements were 10.5% vs. 12.9% respectively. In 2590 cases available for comparison, ET-response was 64.2% centrally (vs. 60.7% locally). The sensitivity of local ET-response detection compared to central “ground truth” was 82.1%; the corresponding specificity (i.e., detecting non-response) was 77.8%. Only 206 of 1571 (13,1%) locally defined ET-responders (8% of tumors with post-endocrine local Ki67 < 5%) were central ET-non-responders, i.e., the positive predictive value (PPV) of local ET-response was 86.9%.

Conclusions

The high PPV and overall excellent concordance suggest a low risk of under-therapy and imply that local assessment of post-endocrine Ki67 in clinical routine is feasible and reliable in HR+HER2- EBC. Publication History Article published online: 03 May 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Hamann, M., Gluz, O., Christgen, M., Nitz, U., Kuemmel, S., Braun, M., Thill, M., Wuerstlein, R., Wimberger, P., Hartkopf, A., Schem, C., Zaiss, M., Bjelic-Radisic, V., Just, M., Veselinovic, K., Vincent, M., Graeser, M., Krauss, K., Hoffmann, O., …, & Harbeck, N. (2024). Endocrine response assessment by Ki67: Concordance of central versus local Ki67 measurements in the ADAPTcycle trial. Senologie - Zeitschrift für Mammadiagnostik und -therapie, 21(02), e11-e12. https://doi.org/10.1055/s-0044-1786090

Vancouver

Hamann M, Gluz O, Christgen M, Nitz U, Kuemmel S, Braun M, et al. Endocrine response assessment by Ki67: Concordance of central versus local Ki67 measurements in the ADAPTcycle trial. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 2024;21(02):e11-e12. doi:10.1055/s-0044-1786090

BibTeX
@article{Hamann2024,
  author = {Hamann, M. and Gluz, O. and Christgen, M. and Nitz, U. and Kuemmel, S. and Braun, M. and Thill, M. and Wuerstlein, R. and Wimberger, P. and Hartkopf, A. and Schem, C. and Zaiss, M. and Bjelic-Radisic, V. and Just, M. and Veselinovic, K. and Vincent, M. and Graeser, M. and Krauss, K. and Hoffmann, O. and Lüdtke-Heckenkamp, K. and Kates, R. and Eulenburg, C. zu and Jozwiak, K. and Burmeister, S. and Baehner, R. and Schmid, P. and Kreipe, H.-H. and Harbeck, N.},
  title = {Endocrine response assessment by Ki67: Concordance of central versus local Ki67 measurements in the ADAPTcycle trial},
  journal = {Senologie - Zeitschrift für Mammadiagnostik und -therapie},
  year = {2024},
  volume = {21},
  number = {02},
  pages = {e11--e12},
  doi = {10.1055/s-0044-1786090}
}
Kostenlos starten →